The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis

Clin Rheumatol. 2007 Jul;26(7):1176-9. doi: 10.1007/s10067-006-0310-6. Epub 2006 Apr 28.

Abstract

We present a 47-year-old Caucasian female who initially presented with mild discoid lupus erythematosus that evolved into systemic lupus erythematosus with subacute cutaneous LE and treatment-recalcitrant lupus panniculitis. Conventional therapy with antimalarials, systemic steroids, azathioprine, cyclophosphamide, methotrexate, and pulse doses of methylprednisolone did not control the course of the disease. Cyclosporin-A treatment led to clinical improvement and maintained remission.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / therapeutic use
  • Azathioprine / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Cyclosporine / therapeutic use*
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / etiology
  • Lupus Erythematosus, Systemic / pathology*
  • Methotrexate / therapeutic use
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Panniculitis, Lupus Erythematosus / complications
  • Panniculitis, Lupus Erythematosus / drug therapy
  • Panniculitis, Lupus Erythematosus / pathology*
  • Pulse Therapy, Drug
  • Tacrolimus / administration & dosage
  • Treatment Failure

Substances

  • Antimalarials
  • Immunosuppressive Agents
  • Hydroxychloroquine
  • Cyclosporine
  • Cyclophosphamide
  • Azathioprine
  • Tacrolimus
  • Methylprednisolone
  • Methotrexate